症状・状態
18 エビデンスに基づいたサプリメント研究のある健康状態
Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.
How We Grade Evidence
各症状ページでは、臨床エビデンスの強さに基づいてサプリメント成分をランク付けしています。各グレードの意味は以下の通りです:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
Perimenopause Cognitive Changes
Affects up to 60% of women during perimenopause (typically ages 45-55)
Age-Related Cognitive Decline
Affects virtually all adults to some degree after age 50
Post-Concussion Cognitive Symptoms
1.6-3.8 million concussions/year in the US; 10-30% develop persistent symptoms
Chemotherapy-Related Cognitive Impairment
Reported by 17-75% of cancer patients undergoing chemotherapy
Brain Fog
Reported by 20-30% of the general population
Attention & Focus Difficulties
Among the most reported cognitive complaints across all age groups
Mental Fatigue
Highly prevalent in modern knowledge-work environments
Sleep-Related Cognitive Impairment
35% of adults sleep less than 7 hours; 50-70 million have sleep disorders
Oxidative Stress & Neuroinflammation
Universal process that accelerates with age and environmental exposure
Neurotransmitter Imbalance
Contributing factor in most cognitive and mood disorders
Long COVID Cognitive Symptoms
Reported by 20-30% of COVID-19 survivors
Cerebrovascular Health
Cerebrovascular risk factors present in 60%+ of adults over 60
Mild Cognitive Impairment (MCI)
15-20% of adults over 65
Memory Loss
40% of adults over 65 experience some form of age-associated memory impairment
Anxiety-Related Cognitive Impairment
Anxiety disorders affect 19% of US adults annually
Depression-Related Cognitive Dysfunction
8.4% of US adults experience major depression; cognitive symptoms in 90%+ of episodes
Stress-Induced Cognitive Decline
Chronic stress reported by 77% of US adults
Nutritional Deficiency Cognitive Impairment
40% of geriatric memory patients deficient in at least one brain-related vitamin
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。